Uluwehi O "Mildronat" (intramuscularly)

Injections "Mildronate" he hoʻonui i ka inhibition o ka y-butyrobetaine hydroxylase, hoʻonāukiuki hakumakuma o ka nui o ka noa carnitine karnitinozavisimoe emi ma ka momomaʻakika'okesaside. Ka lāʻau 'kōkua i ka hoʻoikaika' metabolic keʻano o ka hanaʻana, maoli ka hoʻokōʻana, ho'ēmi i kā ka hōʻike o ke kino ai 'a me ka noʻonoʻo' ke kanana nei. Ka hale mai no hoi i ka cardioprotective hopena. Uluwehi O "Mildronat" (IM) kōkua e hooponopono i aeea-mediated e hoʻonele, eliminates haunaele ma ka'emi'ōnaehana o ka loiloi maoli i maʻi alcoholism ma luna o ke kāʻei kua o ka withdrawal maʻi pale. Ka lapaʻau 'ole i loko o ka redistribution o ke koko i ischemic mau mea,ʻo ia i loko o ka retina a me ka lolo.

Uluwehi O "Mildronat" (IM) ua ia me ka hoemiia e hana ana nona iho, physical ke kanana nei, 'âlapa like hoʻi. Ka lapaʻauʻia e waiho ana ma ka iapaau ana o ischemic naau maʻi (angina, maʻi maʻi, myocardial infarction a me ka cardiomyopathy dyshormonal) i ole ana, alaila maʻi pale ma luna o ke kāʻei kua o ka maʻi alcoholism (ma ka hui pu ana me kekahi Inc). Medicine "Mildronate" (i.m.) ua hoʻohana 'ia, a me kāna hana (maʻi a me ka huʻi) cerebral koko lako, oa. E. Ma ka iapaau ana o ka mapuna hoe a maʻi ole. Ma kēia hihia, ua hoʻohana 'ia ka lāʻau i loko o ka luna' Inc.

Ka hapa-ola o ka lāʻau 'ekolu iʻeono hola.

I ka maʻi alcoholism lāʻau "Mildronat" (IM) ua paipai palua ka lā no ka hapalua o ka gram kela la i keia no ka ehiku a umi lā.

I ka noʻonoʻo a me ka physical overload ka lapaʻauʻia ua pono no kanaka makua nā mea maʻi i loko o eha manawa i ka lā ma 0,25 nā huna a 0.5 nā huna intravenously kekahi manawa i ka lā. Ka lōʻihi like 'ole o ka Inc mai he umi i kaʻumikumamāhā mau lā. Inā pono, ua paipaiʻia ma hope o elua a ekolu pule o ka lua o ka papa. 'Âlapa hoonoho Kalaiaina,ʻelua hahauʻana i ka lā ma mua hoʻokō' o 0.5-1 nā huna. Ma ka hoomakaukau wā lōʻihi like 'ole o ka papa - chetyrnadtsat- iwakalua-kekahi lā, a me ka manawa o ka Competition - he umi i kaʻumikumamāhā mau lā.

I Ina o ka insufficiency o cerebral holo i loko o ka huʻi pae o ka cerebrovascular pathology ua kuhikuhi intravenously i elima ka pono o umi pakeneka pāʻoihana kela la i keia no na la he umi. Eia, i ka lāʻau 'ua hoakaka ia maloko o ka hapalua o ka gram o ka lā. Ka Inc Duration - elua a ekolu pule.

E hoomakaukau ai "Mildronate" ( 'o ia hoʻi analogs, e laʻa me, medicament "carnitine") ua contraindicated ma ka hypersensitivity a CNS lesions ke aloha ano.

I ana i ka lāʻau 'malama dyspeptic symptoms, pruritus, manaʻo pīhoihoi, tachycardia, loli ma arterial puʻe.

'Aʻole i hoʻouka kekahi kūlana palekana o ka lapaʻauʻia ma ka hāpai keiki. Ma keia manao, o ia hoʻi, "Mildronate" (intramuscularly, intravenously a me ka hōʻike waha ') ua ole ia. Inā pono, hoʻohana i lactation e hooki lakou e hanai ana oia.